Skip to main content

Voyager Therapeutics, Inc.

VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001640266

No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Voyager Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
133
+8 vs. Q3 2024
Shares held
34.6M
−398.5K (−1.1%) vs. Q3 2024
Total value
$196.2M
−$8.79M (−4.3%) vs. Q3 2024
New holders
26
44 more added
Sold out
18
37 more reduced

3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 133 institutions
Q1 2021: 101 institutionsQ2 2021: 78 institutionsQ3 2021: 69 institutionsQ4 2021: 59 institutionsQ1 2022: 70 institutionsQ2 2022: 78 institutionsQ3 2022: 69 institutionsQ4 2022: 70 institutionsQ1 2023: 82 institutionsQ2 2023: 106 institutionsQ3 2023: 111 institutionsQ4 2023: 107 institutionsQ1 2024: 132 institutionsQ2 2024: 127 institutionsQ3 2024: 128 institutionsQ4 2024: 133 institutionsQ1 2025: 116 institutionsQ2 2025: 113 institutionsQ3 2025: 117 institutionsQ4 2025: 125 institutionsQ1 2026: 135 institutionsQ2 2026: 135 institutions
Value heldQ4 2024: $196.2M
Q1 2021: $125.7MQ2 2021: $96.8MQ3 2021: $58.6MQ4 2021: $51.3MQ1 2022: $171.3MQ2 2022: $142.3MQ3 2022: $142.9MQ4 2022: $146.2MQ1 2023: $183.8MQ2 2023: $307.7MQ3 2023: $211.2MQ4 2023: $227.5MQ1 2024: $331.1MQ2 2024: $301.6MQ3 2024: $205.9MQ4 2024: $196.2MQ1 2025: $117.4MQ2 2025: $103.1MQ3 2025: $141.1MQ4 2025: $132.6MQ1 2026: $129.4MQ2 2026: $122.7M
Institutions holding VYGR and their total value by quarter
QuarterHoldersValue
Q2 2026135$122.7M
Q1 2026135$129.4M
Q4 2025125$132.6M
Q3 2025117$141.1M
Q2 2025113$103.1M
Q1 2025116$117.4M
Q4 2024133$196.2M
Q3 2024128$205.9M
Q2 2024127$301.6M
Q1 2024132$331.1M
Q4 2023107$227.5M
Q3 2023111$211.2M
Q2 2023106$307.7M
Q1 202382$183.8M
Q4 202270$146.2M
Q3 202269$142.9M
Q2 202278$142.3M
Q1 202270$171.3M
Q4 202159$51.3M
Q3 202169$58.6M
Q2 202178$96.8M
Q1 2021101$125.7M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding VYGR in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Barclays PLC114,790$650.9K0.00%+10,328+9.9%Added
TD Asset Management Inc114,930$651.7K0.00%00.0%Unchanged
American Century Companies Inc122,726$695.9K0.00%+9,190+8.1%Added
Gsa Capital Partners LLP123,459$700.0K0.05%+123,459New
ADAR1 Capital Management, LLC126,792$718.9K0.15%+86,158+212.0%Added
Captrust Financial Advisors128,759$730.1K0.00%+313+0.2%Added
Raymond James Financial Inc131,505$745.6K0.00%+131,505New
Charles Schwab Investment Management Inc137,571$780.0K0.00%+94+0.1%Added
Renaissance Technologies LLC139,900$793.2K0.00%−138,767−49.8%Reduced
AQR Capital Management LLC177,333$1.01M0.00%−71,290−28.7%Reduced
Massachusetts Financial Services Co186,000$1.05M0.00%+14,144+8.2%Added
Bank of New York Mellon Corp193,315$1.10M0.00%−56,213−22.5%Reduced
UBS Group AG199,310$1.13M0.00%+175,047+721.5%Added
JPMorgan Chase & Co241,634$1.37M0.00%−20,300−7.8%Reduced
Fiduciary Trust Co259,397$1.47M0.02%00.0%Unchanged
Wellington Management Group LLP261,251$1.48M0.00%+31,882+13.9%Added
Goldman Sachs Group Inc291,252$1.65M0.00%−37,074−11.3%Reduced
Globeflex Capital L P291,293$1.65M0.14%00.0%Unchanged
Prudential Financial Inc330,300$1.87M0.00%−82,100−19.9%Reduced
Northern Trust Corp418,745$2.37M0.00%+12,374+3.0%Added
Morgan Stanley447,141$2.54M0.00%−93,522−17.3%Reduced
Great Point Partners LLC826,751$4.69M2.21%−133,202−13.9%Reduced
Price T Rowe Associates Inc862,432$4.89M0.00%−43,388−4.8%Reduced
State Street Corp900,932$5.11M0.00%+8,189+0.9%Added
Erste Asset Management GmbH1,058,378$5.94M0.07%00.0%Unchanged
Geode Capital Management, LLC1,084,238$6.15M0.00%+4,729+0.4%Added
Vestal Point Capital, LP1,230,000$6.97M0.41%+740,000+151.0%Added
Dimensional Fund Advisors LP1,380,615$7.83M0.00%+275,571+24.9%Added
Farallon Capital Management, L.L.C.2,570,700$14.6M0.08%+278,700+12.2%Added
Vanguard Group Inc3,215,441$18.2M0.00%+29,014+0.9%Added
EcoR1 Capital, LLC3,917,546$22.2M0.89%00.0%Unchanged
BlackRock, Inc.5,356,789$30.4M0.00%−73,641−1.4%Reduced
Armistice Capital, LLC5,396,000$30.6M0.71%+196,000+3.8%Added
Federated Hermes, Inc.0$00.00%−551,398−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−118,828−100.0%Sold out
Affinity Asset Advisors, LLC0$00.00%−51,727−100.0%Sold out
Corton Capital Inc.0$00.00%−32,028−100.0%Sold out
PDT Partners, LLC0$00.00%−22,163−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−17,300−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−13,939−100.0%Sold out
Jump Financial, LLC0$00.00%−10,999−100.0%Sold out
Cornercap Investment Counsel Inc0$00.00%−10,937−100.0%Sold out
nVerses Capital, LLC0$00.00%−1,900−100.0%Sold out
Washington Trust Co0$00.00%−500−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−411−100.0%Sold out
Country Trust Bank0$00.00%−300−100.0%Sold out
Frazier Financial Advisors, LLC0$00.00%−255−100.0%Sold out
Moisand Fitzgerald Tamayo, LLC0$00.00%−185−100.0%Sold out
Covestor Ltd0$00.00%−101−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−75−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−16−100.0%Sold out
ClariVest Asset Management LLC––––Not filed
Raymond James Financial Services Advisors, Inc.––––Not filed
Planning Capital Management Corp––––Not filed